mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.007 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.007 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.007 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.007 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.008 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |